Associations of Frequency of Laughter With Risk of All-Cause Mortality and Cardiovascular Disease Incidence in a General Population: Findings From the Yamagata Study.


Journal

Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688

Informations de publication

Date de publication:
05 Apr 2020
Historique:
pubmed: 9 4 2019
medline: 20 11 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

Positive and negative psychological factors are associated with mortality and cardiovascular disease. This study prospectively investigated associations of daily frequency of laughter with mortality and cardiovascular disease in a community-based population. This study included 17,152 subjects ≥40 years old who participated in an annual health check in Yamagata Prefecture. Self-reported daily frequency of laughter was grouped into three categories (≥1/week; ≥1/month but <1/week; <1/month). Associations of daily frequency of laughter with increase in all-cause mortality and cardiovascular disease incidence were determined using Cox proportional hazards modeling. During follow-up (median, 5.4 years), 257 subjects died and 138 subjects experienced cardiovascular events. Kaplan-Meier analysis revealed that all-cause mortality and cardiovascular disease incidence were significantly higher among subjects with a low frequency of laughter (log-rank P < 0.01). Cox proportional hazard model analysis adjusted for age, gender, hypertension, smoking, and alcohol drinking status showed that risk of all-cause mortality was significantly higher in subjects who laughed <1/month than in subjects who laughed ≥1/week (hazard ratio [HR] 1.95; 95% confidence interval [CI], 1.16-3.09). Similarly, risk of cardiovascular events was higher in subjects who laughed ≥1/month but <1/week than in subjects who laughed ≥1/week (HR 1.62; 95% CI, 1.07-2.40). Daily frequency of laughter represents an independent risk factor for all-cause mortality and cardiovascular disease in a Japanese general population.

Sections du résumé

BACKGROUND BACKGROUND
Positive and negative psychological factors are associated with mortality and cardiovascular disease. This study prospectively investigated associations of daily frequency of laughter with mortality and cardiovascular disease in a community-based population.
METHODS METHODS
This study included 17,152 subjects ≥40 years old who participated in an annual health check in Yamagata Prefecture. Self-reported daily frequency of laughter was grouped into three categories (≥1/week; ≥1/month but <1/week; <1/month). Associations of daily frequency of laughter with increase in all-cause mortality and cardiovascular disease incidence were determined using Cox proportional hazards modeling.
RESULTS RESULTS
During follow-up (median, 5.4 years), 257 subjects died and 138 subjects experienced cardiovascular events. Kaplan-Meier analysis revealed that all-cause mortality and cardiovascular disease incidence were significantly higher among subjects with a low frequency of laughter (log-rank P < 0.01). Cox proportional hazard model analysis adjusted for age, gender, hypertension, smoking, and alcohol drinking status showed that risk of all-cause mortality was significantly higher in subjects who laughed <1/month than in subjects who laughed ≥1/week (hazard ratio [HR] 1.95; 95% confidence interval [CI], 1.16-3.09). Similarly, risk of cardiovascular events was higher in subjects who laughed ≥1/month but <1/week than in subjects who laughed ≥1/week (HR 1.62; 95% CI, 1.07-2.40).
CONCLUSION CONCLUSIONS
Daily frequency of laughter represents an independent risk factor for all-cause mortality and cardiovascular disease in a Japanese general population.

Identifiants

pubmed: 30956258
doi: 10.2188/jea.JE20180249
pmc: PMC7064551
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-193

Références

Age (Dordr). 2006 Dec;28(4):343-52
pubmed: 22253500
PLoS One. 2013 Dec 13;8(12):e83725
pubmed: 24349548
Clin Exp Nephrol. 2013 Dec;17(6):805-10
pubmed: 23345069
Circulation. 2009 Sep 15;120(11):956-63
pubmed: 19720937
Sci Rep. 2017 Jan 16;7:40363
pubmed: 28091607
Qual Life Res. 2018 Mar;27(3):639-650
pubmed: 29198044
Altern Ther Health Med. 2003 Mar-Apr;9(2):38-45
pubmed: 12652882
Geriatr Gerontol Int. 2013 Jan;13(1):152-60
pubmed: 22672359
J Atheroscler Thromb. 2015;22(10):1030-9
pubmed: 26016512
Heart. 2006 Feb;92(2):261-2
pubmed: 16415199
Aging (Albany NY). 2012 May;4(5):359-67
pubmed: 22626632
J Epidemiol. 2016 Oct 5;26(10):546-552
pubmed: 26972732
Am J Cardiol. 2010 Sep 15;106(6):856-9
pubmed: 20816128
Diabetes Care. 2003 May;26(5):1651-2
pubmed: 12716853
Science. 2011 Feb 4;331(6017):542-3
pubmed: 21292959
BMJ Open. 2018 Jul 5;8(7):e019104
pubmed: 29980539
Metabolism. 2012 Apr;61(4):504-11
pubmed: 22001336
J Psychosom Res. 2009 Jul;67(1):67-75
pubmed: 19539820
Clin Exp Nephrol. 2016 Dec;20(6):904-909
pubmed: 26779905
Age (Dordr). 2006 Dec;28(4):353-61
pubmed: 22253501
Biomed Res. 2007 Apr;28(2):115-8
pubmed: 17510497
Int J Mol Med. 2001 Dec;8(6):645-50
pubmed: 11712080
Nature. 2012 Oct 11;490(7419):169-71
pubmed: 23060172

Auteurs

Kaori Sakurada (K)

Department of Fundamental Nursing, Yamagata University Faculty of Medicine School of Nursing.

Tsuneo Konta (T)

Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science.

Masafumi Watanabe (M)

Global Center of Excellence Program Study Group, Yamagata University School of Medicine.

Kenichi Ishizawa (K)

Global Center of Excellence Program Study Group, Yamagata University School of Medicine.

Yoshiyuki Ueno (Y)

Global Center of Excellence Program Study Group, Yamagata University School of Medicine.

Hidetoshi Yamashita (H)

Global Center of Excellence Program Study Group, Yamagata University School of Medicine.

Takamasa Kayama (T)

Global Center of Excellence Program Study Group, Yamagata University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH